A distinct transition from cell growth to physiological homeostasis in the tendon

  1. Mor Grinstein
  2. Heather L Dingwall
  3. Luke D O'Connor
  4. Ken Zou
  5. Terence Dante Capellini
  6. Jenna Lauren Galloway  Is a corresponding author
  1. Massachusetts General Hospital, Harvard Medical School, United States
  2. Harvard University, United States

Abstract

Changes in cell proliferation define transitions from tissue growth to physiological homeostasis. In tendons, a highly organized extracellular matrix undergoes significant postnatal expansion to drive growth, but once formed, it appears to undergo little turnover. However, tendon cell activity during growth and homeostatic maintenance is less well defined. Using complementary methods of genetic H2B-GFP pulse-chase labeling and BrdU incorporation in mice, we show significant postnatal tendon cell proliferation, correlating with longitudinal Achilles tendon growth. Around day 21, there is a transition in cell turnover with a significant decline in proliferation. After this time, we find low amounts of homeostatic tendon cell proliferation from 3 to 20 months. These results demonstrate that tendons harbor significant postnatal mitotic activity, and limited, but detectable activity in adult and aged stages. It also points towards the possibility that the adult tendon harbors resident tendon progenitor populations, which would have important therapeutic implications.

Data availability

All data generated or analyzed in this study are included in the manuscript and supporting files. Source data and R code have been provided for Figure 4.

Article and author information

Author details

  1. Mor Grinstein

    Center for Regenerative Medicine, Department of Orthopaedic Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, United States
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-7166-5593
  2. Heather L Dingwall

    Department of Human Evolutionary Biology, Harvard University, Cambridge, United States
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-2377-9777
  3. Luke D O'Connor

    Center for Regenerative Medicine, Department of Orthopaedic Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, United States
    Competing interests
    The authors declare that no competing interests exist.
  4. Ken Zou

    Center for Regenerative Medicine, Department of Orthopaedic Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, United States
    Competing interests
    The authors declare that no competing interests exist.
  5. Terence Dante Capellini

    Department of Human Evolutionary Biology, Harvard University, Cambridge, United States
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-3842-8478
  6. Jenna Lauren Galloway

    Center for Regenerative Medicine, Department of Orthopaedic Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, United States
    For correspondence
    JGALLOWAY@mgh.harvard.edu
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-3792-3290

Funding

National Institute of Arthritis and Musculoskeletal and Skin Diseases (AR071554)

  • Mor Grinstein
  • Heather L Dingwall
  • Ken Zou
  • Terence Dante Capellini
  • Jenna Lauren Galloway

National Institute of Arthritis and Musculoskeletal and Skin Diseases (AR072294)

  • Jenna Lauren Galloway

American Federation for Aging Research

  • Jenna Lauren Galloway

Harvard Stem Cell Institute

  • Jenna Lauren Galloway

Human Frontier Science Program (Fellowship)

  • Mor Grinstein

Milton Fund

  • Terence Dante Capellini

Harvard University Dean's Competitive Fund

  • Terence Dante Capellini

National Science Foundation (Predoctoral fellowship)

  • Heather L Dingwall

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Reviewing Editor

  1. Clifford J Rosen, Maine Medical Center Research Institute, United States

Ethics

Animal experimentation: This study was performed according to our protocol approved by the Massachusetts General Hospital Institutional Animal Care and Use Committee (IACUC: 2013N000062), and adheres to the recommendations in the Guide for the Care and Use of Laboratory Animals of the NIH.

Version history

  1. Received: May 22, 2019
  2. Accepted: September 18, 2019
  3. Accepted Manuscript published: September 19, 2019 (version 1)
  4. Version of Record published: October 14, 2019 (version 2)

Copyright

© 2019, Grinstein et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 2,537
    views
  • 325
    downloads
  • 31
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Mor Grinstein
  2. Heather L Dingwall
  3. Luke D O'Connor
  4. Ken Zou
  5. Terence Dante Capellini
  6. Jenna Lauren Galloway
(2019)
A distinct transition from cell growth to physiological homeostasis in the tendon
eLife 8:e48689.
https://doi.org/10.7554/eLife.48689

Share this article

https://doi.org/10.7554/eLife.48689

Further reading

    1. Developmental Biology
    Zhimin Xu, Zhao Wang ... Yingchuan B Qi
    Research Article

    Precise developmental timing control is essential for organism formation and function, but its mechanisms are unclear. In C. elegans, the microRNA lin-4 critically regulates developmental timing by post-transcriptionally downregulating the larval-stage-fate controller LIN-14. However, the mechanisms triggering the activation of lin-4 expression toward the end of the first larval stage remain unknown. We demonstrate that the transmembrane transcription factor MYRF-1 is necessary for lin-4 activation. MYRF-1 is initially localized on the cell membrane, and its increased cleavage and nuclear accumulation coincide with lin-4 expression timing. MYRF-1 regulates lin-4 expression cell-autonomously and hyperactive MYRF-1 can prematurely drive lin-4 expression in embryos and young first-stage larvae. The tandem lin-4 promoter DNA recruits MYRF-1GFP to form visible loci in the nucleus, suggesting that MYRF-1 directly binds to the lin-4 promoter. Our findings identify a crucial link in understanding developmental timing regulation and establish MYRF-1 as a key regulator of lin-4 expression.

    1. Developmental Biology
    2. Structural Biology and Molecular Biophysics
    Samuel C Griffiths, Jia Tan ... Hsin-Yi Henry Ho
    Research Article Updated

    The receptor tyrosine kinase ROR2 mediates noncanonical WNT5A signaling to orchestrate tissue morphogenetic processes, and dysfunction of the pathway causes Robinow syndrome, brachydactyly B, and metastatic diseases. The domain(s) and mechanisms required for ROR2 function, however, remain unclear. We solved the crystal structure of the extracellular cysteine-rich (CRD) and Kringle (Kr) domains of ROR2 and found that, unlike other CRDs, the ROR2 CRD lacks the signature hydrophobic pocket that binds lipids/lipid-modified proteins, such as WNTs, suggesting a novel mechanism of ligand reception. Functionally, we showed that the ROR2 CRD, but not other domains, is required and minimally sufficient to promote WNT5A signaling, and Robinow mutations in the CRD and the adjacent Kr impair ROR2 secretion and function. Moreover, using function-activating and -perturbing antibodies against the Frizzled (FZ) family of WNT receptors, we demonstrate the involvement of FZ in WNT5A-ROR signaling. Thus, ROR2 acts via its CRD to potentiate the function of a receptor super-complex that includes FZ to transduce WNT5A signals.